Fortress Biotech, Inc. (FBIO)

Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	91.34	57.26	80.93	178.27	305.74	233.35
Cash & Short-Term Investments	91.34	57.26	80.93	178.27	305.74	233.35
Cash Growth	9.03%	-29.24%	-54.60%	-41.69%	31.02%	70.51%
Accounts Receivable	18.03	10.23	15.22	28.21	23.11	23.93
Other Receivables	0.31	0.17	0.17	0.14	0.68	0.74
Receivables	18.33	10.4	15.39	28.35	23.79	24.67
Inventory	12.5	14.43	10.21	14.16	9.86	1.4
Prepaid Expenses	4.73	7.11	10.5	9.66	7.07	6.72
Other Current Assets	-	1.17	-	-	-	-
Total Current Assets	126.9	90.37	117.02	230.43	346.46	266.15
Property, Plant & Equipment	16.1	17.12	23.5	33.01	34.07	32.41
Long-Term Investments	-	-	-	-	-	17.57
Other Intangible Assets	30.8	31.86	20.29	27.2	12.55	14.63
Other Long-Term Assets	4.27	4.87	6.72	3.66	3.42	2.66
Total Assets	178.07	144.22	167.53	294.3	396.5	333.41
Accounts Payable	66.29	31.64	34.81	57.24	47.43	11.41
Accrued Expenses	-	30.74	34.68	36.51	39.99	31.26
Short-Term Debt	1.88	-	3.93	5	0.81	-
Current Portion of Long-Term Debt	-	0.63	3	7.24	4.51	4.52
Current Portion of Leases	2.16	2.62	2.52	2.45	2.1	1.85
Current Income Taxes Payable	0.95	0.93	0.84	0.72	0.35	0.14
Current Unearned Revenue	-	-	-	-	2.61	-
Other Current Liabilities	2.4	4.84	5.13	18.55	3.24	2.58
Total Current Liabilities	73.67	71.4	84.91	127.72	101.04	51.76
Long-Term Debt	56.38	57.96	60.86	93.14	46.56	59.81
Long-Term Leases	13.82	14.75	18.28	21.57	20.99	22.89
Other Long-Term Liabilities	1.71	1.76	1.89	1.85	2.03	1.95
Total Liabilities	145.59	145.87	165.94	244.28	170.63	136.41
Common Stock	0.03	0.03	0.02	0.01	0.1	0.1
Additional Paid-In Capital	773.67	763.57	717.4	675.94	656.03	583
Retained Earnings	-751.45	-740.87	-694.87	-634.23	-547.46	-482.76
Total Common Equity	22.25	22.73	22.54	41.72	108.67	100.34
Minority Interest	10.24	-24.38	-20.96	8.3	117.2	96.66
Shareholders' Equity	32.49	-1.64	1.59	50.03	225.88	197
Total Liabilities & Equity	178.07	144.22	167.53	294.3	396.5	333.41
Total Debt	74.24	75.96	88.59	129.4	74.98	89.08
Net Cash (Debt)	17.1	-18.7	-7.67	48.87	230.77	144.28
Net Cash Growth	-	-	-	-78.82%	59.95%	564.37%
Net Cash Per Share	0.74	-0.90	-0.95	8.25	42.37	30.06
Filing Date Shares Outstanding	29.55	29.53	19.23	8.65	6.97	6.33
Total Common Shares Outstanding	29.55	27.91	15.09	7.37	6.76	6.33
Working Capital	53.23	18.97	32.11	102.72	245.42	214.39
Book Value Per Share	0.75	0.81	1.49	5.66	16.07	15.86
Tangible Book Value	-8.55	-9.13	2.25	14.52	96.12	85.71
Tangible Book Value Per Share	-0.29	-0.33	0.15	1.97	14.21	13.55
Buildings	-	0.58	0.58	0.58	0.58	-
Machinery	-	1.61	1.61	10.76	8.68	7.61
Construction In Progress	-	-	0.03	0.95	2.03	0.5
Leasehold Improvements	-	11	13.18	13.18	13.18	10.58

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q